tiprankstipranks
Trending News
More News >
iHuman (IH)
NYSE:IH
US Market

iHuman (IH) Ratios

Compare
94 Followers

iHuman Ratios

IH's free cash flow for Q2 2025 was ¥0.68. For the 2025 fiscal year, IH's free cash flow was decreased by ¥ and operating cash flow was ¥0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.55 2.98 2.82 2.23 2.10
Quick Ratio
3.49 2.93 2.78 2.20 2.04
Cash Ratio
1.70 2.51 2.47 1.87 1.77
Solvency Ratio
0.30 0.24 0.39 0.21 -0.06
Operating Cash Flow Ratio
0.00 0.13 0.35 2.30 0.08
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 128.36M¥ 877.02M¥ 889.75M¥ 689.84M¥ 522.73M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 <0.01 <0.01 0.03
Debt-to-Equity Ratio
0.01 0.02 <0.01 0.01 0.06
Debt-to-Capital Ratio
0.01 0.02 <0.01 0.01 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.38 1.48 1.51 1.73 1.81
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
1.19 1.42 0.07 0.03 0.13
Net Debt to EBITDA
-1.20 -12.95 -7.05 -8.50 17.17
Profitability Margins
Gross Profit Margin
67.95%69.42%70.84%70.13%69.93%
EBIT Margin
8.69%7.80%15.70%11.32%-5.74%
EBITDA Margin
8.69%9.28%16.85%12.42%-5.06%
Operating Profit Margin
8.69%7.80%15.70%11.32%-5.74%
Pretax Profit Margin
13.57%11.99%19.90%13.47%-3.94%
Net Profit Margin
12.47%10.69%17.77%11.14%-3.92%
Continuous Operations Profit Margin
12.47%10.69%17.77%11.14%-3.92%
Net Income Per EBT
91.89%89.14%89.30%82.71%99.61%
EBT Per EBIT
156.12%153.80%126.70%118.99%68.57%
Return on Assets (ROA)
45.74%6.94%12.47%8.24%-3.37%
Return on Equity (ROE)
11.68%10.26%18.89%14.27%-6.09%
Return on Capital Employed (ROCE)
41.82%7.40%16.66%14.45%-8.78%
Return on Invested Capital (ROIC)
38.98%6.57%14.85%11.86%-8.41%
Return on Tangible Assets
46.30%7.03%12.68%8.39%-3.45%
Earnings Yield
57.93%76.27%77.10%11.49%-3.94%
Efficiency Ratios
Receivables Turnover
15.28 17.05 16.25 12.03 16.02
Payables Turnover
13.34 9.33 13.41 12.16 9.30
Inventory Turnover
13.69 12.01 17.97 15.39 10.13
Fixed Asset Turnover
59.12 50.23 103.71 44.82 18.70
Asset Turnover
0.66 0.65 0.70 0.74 0.86
Working Capital Turnover Ratio
0.99 1.04 1.29 1.61 1.64
Cash Conversion Cycle
3.45 12.66 15.55 24.03 19.60
Days of Sales Outstanding
5.01 21.40 22.46 30.33 22.79
Days of Inventory Outstanding
4.84 30.38 20.31 23.72 36.04
Days of Payables Outstanding
6.40 39.12 27.22 30.02 39.23
Operating Cycle
9.86 51.78 42.77 54.05 58.83
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 5.59 3.26 4.85 0.14
Free Cash Flow Per Share
0.00 4.88 3.14 4.68 0.02
CapEx Per Share
0.00 0.71 0.12 0.17 0.12
Free Cash Flow to Operating Cash Flow
0.00 0.87 0.96 0.97 0.16
Dividend Paid and CapEx Coverage Ratio
0.00 1.37 26.44 28.61 1.18
Capital Expenditure Coverage Ratio
0.00 7.86 26.44 28.61 1.18
Operating Cash Flow Coverage Ratio
0.00 3.93 44.59 143.21 1.12
Operating Cash Flow to Sales Ratio
0.00 0.06 0.17 1.31 0.04
Free Cash Flow Yield
0.00%39.53%14.12%26.07%0.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.38 1.31 1.30 8.70 -25.41
Price-to-Sales (P/S) Ratio
0.17 0.14 0.23 0.97 1.00
Price-to-Book (P/B) Ratio
0.16 0.13 0.24 1.24 1.55
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 2.53 1.42 0.77 158.73
Price-to-Operating Cash Flow Ratio
0.00 2.21 1.36 0.74 24.64
Price-to-Earnings Growth (PEG) Ratio
0.18 -0.03 0.02 -0.02 1.62
Price-to-Fair Value
0.16 0.13 0.24 1.24 1.55
Enterprise Value Multiple
-5.72 -11.44 -5.68 -0.69 -2.51
Enterprise Value
82.96M -979.11M -36.73M 3.74B 3.89B
EV to EBITDA
1.40 -11.44 -0.21 30.54 -81.24
EV to Sales
0.12 -1.06 -0.04 3.79 4.11
EV to Free Cash Flow
0.00 -19.16 -0.22 3.00 655.19
EV to Operating Cash Flow
0.00 -16.72 -0.21 2.90 101.69
Tangible Book Value Per Share
94.31 90.12 17.70 2.79 2.20
Shareholders’ Equity Per Share
94.31 91.68 18.14 2.89 2.30
Tax and Other Ratios
Effective Tax Rate
0.08 0.11 0.11 0.17 <0.01
Revenue Per Share
85.87 88.00 19.28 3.70 3.57
Net Income Per Share
10.70 9.41 3.43 0.41 -0.14
Tax Burden
0.93 0.89 0.89 0.83 1.00
Interest Burden
1.59 1.54 1.27 1.19 0.69
Research & Development to Revenue
0.27 0.27 0.25 0.32 0.44
SG&A to Revenue
0.11 0.11 0.10 0.11 0.10
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.09 0.02
Income Quality
0.00 0.59 0.95 1.72 -1.03
Currency in CNY